Eli M. Roth
Impact in
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 37
- Lipoproteins and Cardiovascular Health 32
- Coronary Interventions and Diagnostics 4
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Acute Myocardial Infarction Research 5
- Co-authors
- James M. McKenney (9 shared papers)Evan A. Stein (7 shared papers)Corinne Hanotin (7 shared papers)Gaëlle Asset (2 shared papers)Dirk Jacobus Blom (4 shared papers)Scott M. Wasserman (5 shared papers)Maria Laura Monsalvo (4 shared papers)Christie Mitchell Ballantyne (4 shared papers)
- Journals
- Journal of clinical lipidology (8 papers)Atherosclerosis (5 papers)Journal of the American College of Cardiology (5 papers)American Heart Journal (3 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Eli M. Roth
60 papers receiving 3.0k citations
Eli M. Roth's Hit Papers
Peers
Comparison fields: 5 of 95
- Surgery 2.2k
- Endocrinology, Diabetes and Metabolism 460
- Cardiology and Cardiovascular Medicine 515
- Economics and Econometrics 499
- Cancer Research 239
Countries citing papers authored by Eli M. Roth
This map shows the geographic impact of Eli M. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli M. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli M. Roth more than expected).
Fields of papers citing papers by Eli M. Roth
This network shows the impact of papers produced by Eli M. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli M. Roth. The network helps show where Eli M. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli M. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia Hit paper breakdown → | 2014 | 620 |
| 2 | Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia Hit paper breakdown → | 2012 | 408 |
| 3 | 2014 | 229 | |
| 4 | 2014 | 178 | |
| 5 | 2016 | 112 | |
| 6 | 1999 | 111 | |
| 7 | 2001 | 103 | |
| 8 | 2013 | 94 | |
| 9 | 2010 | 91 | |
| 10 | 2021 | 88 | |
| 11 | 2017 | 80 | |
| 12 | 2015 | 80 | |
| 13 | 2014 | 77 | |
| 14 | 2007 | 71 | |
| 15 | 2009 | 62 | |
| 16 | 2015 | 61 | |
| 17 | 2015 | 61 | |
| 18 | 2014 | 52 | |
| 19 | 2016 | 52 | |
| 20 | 2015 | 48 |
About Eli M. Roth
Eli M. Roth is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Cancer Research, Endocrinology, Diabetes and Metabolism and Immunology, having authored 61 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (32 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Acute Myocardial Infarction Research (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Coronary Interventions and Diagnostics (4 papers), Computational Drug Discovery Methods (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Surgery (2.2k citations), Endocrinology, Diabetes and Metabolism (460 citations), Cardiology and Cardiovascular Medicine (515 citations), Economics and Econometrics (499 citations) and Cancer Research (239 citations). Eli M. Roth has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include James M. McKenney, Evan A. Stein, Corinne Hanotin, Gaëlle Asset, Dirk Jacobus Blom, Scott M. Wasserman, Maria Laura Monsalvo, Christie Mitchell Ballantyne, Robert C. Scott and Michael J. Koren. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, Journal of the American College of Cardiology, American Heart Journal and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.